ARTEETHER API Manufacturer Exporter CAS No.: 75887-54-6 Swapnroop Drugs & Pharmaceuticals
What is ARTEETHER API manufactured by Swapnroop Drugs & Pharmaceuticals?
ARTEETHER API is a semi-synthetic derivative of artemisinin, derived from the plant Artemisia annua, and is primarily used for treating severe and chloroquine-resistant Plasmodium falciparum malaria, including cerebral malaria
π About Swapnroop Drugs & Pharmaceuticals
Swapnroop Drugs & Pharmaceuticals, established in 2013 and based in Aurangabad, Maharashtra, is an ISO 9001:2008 and FDA-approved pharmaceutical company. They specialize in the sales and marketing of Active Pharmaceutical Ingredients (APIs), intermediates, herbal extracts, and pharmaceutical formulations. Their product portfolio includes over 500 molecules catering to various therapeutic areas such as anti-infectives, cardiovascular, CNS, gastrointestinal, and more
⚗️ About Arteether API
Arteether is a fast-acting blood schizonticide effective against the erythrocytic stages of malaria parasites. It is indicated as a second-line treatment for severe P. falciparum malaria, especially in cases resistant to chloroquine. The drug has demonstrated excellent efficacy with a low recrudescence rate in clinical trials
π¦ Packaging & Storage
While specific packaging details from Swapnroop are not provided, standard practices for Arteether API include:
-
Packaging: Typically packed in double-layered LDPE bags placed inside HDPE drums to ensure product stability.
-
Storage: Recommended to store in a cool, dry place, away from moisture and direct sunlight, to maintain efficacy.
π Regulatory & Quality Assurance
Swapnroop Drugs & Pharmaceuticals operates under WHO GMP guidelines and holds ISO 9001:2008 certification. Their products are supported with regulatory documents like Drug Master Files (DMF), Certificate of Analysis (COA), Method of Analysis (MOA), and Material Safety Data Sheets (MSDS), ensuring compliance with global quality standards .
What are the physicochemical properties of ARTEETHER API Manufactured by Swapnroop Drugs and Pharmaceuticals?
Arteether API, manufactured by Swapnroop Drugs & Pharmaceuticals, is a semi-synthetic derivative of artemisinin, primarily used in the treatment of severe and chloroquine-resistant Plasmodium falciparum malaria. Understanding its physicochemical properties is crucial for its formulation and therapeutic efficacy.
π¬ Physicochemical Properties of Arteether API
-
Chemical Name: Arteether
-
CAS Number: 75887-54-6
-
Molecular Formula: C₁₇H₂₈O₅
-
Molecular Weight: 312.40 g/mol
-
Appearance: White crystalline solid
-
Melting Point: 80–82°C
-
Boiling Point: Approximately 372.4°C at 760 mmHg
-
Density: 1.16 g/cm³
-
Optical Rotation: [Ξ±]D²¹ +154.5° (c = 1.0 in CHCl₃)
-
Solubility:
-
Water: Poorly soluble
-
Chloroform & Ethyl Acetate: Slightly soluble
-
DMSO: Highly soluble (62 mg/mL)
-
-
Flash Point: 146°C
-
LogP (Partition Coefficient): Approximately 3.4
-
Hydrogen Bond Donors: 0
-
Hydrogen Bond Acceptors: 5
π§ͺ Formulation Considerations
Due to its poor water solubility, Arteether is classified as a Biopharmaceutical Classification System (BCS) Class II drug. This classification indicates high permeability but low solubility, which can limit its bioavailability. To enhance its solubility and dissolution rate, formulation strategies such as solid dispersion techniques and the use of hydrophilic carriers like Soluplus, PEG-6000, and Poloxamer 407 have been explored. These approaches aim to improve the drug's wettability and reduce its crystallinity, thereby enhancing its therapeutic efficacy
π§΄ Storage & Handling
-
Storage Conditions: Store in a cool, dry place at 2–8°C, away from moisture and direct sunlight.
-
Packaging: Typically packaged in double-layered LDPE bags placed inside HDPE drums to ensure product stability.
-
Shelf Life: Up to 5 years when stored under recommended conditions.
π§ͺ Step-by-Step Synthesis of Arteether API
-
π¬ Extraction of Artemisinin
-
Raw Material: Artemisia annua (sweet wormwood)
-
Method: Solvent extraction (commonly using petroleum ether or hexane), followed by crystallization to purify artemisinin.
-
-
π Reduction of Artemisinin
-
Artemisinin undergoes reduction with NaBH₄ (sodium borohydride) or similar reducing agents to form dihydroartemisinin (DHA).
-
-
⚗️ Etherification
-
DHA is reacted with ethanol (or another suitable alcohol like tert-butanol) in the presence of an acid catalyst (e.g., sulfuric acid or p-toluenesulfonic acid).
-
This results in the formation of the ethyl ether derivative, i.e., Arteether.
-
-
π§Ό Purification
-
The crude product is purified by crystallization or column chromatography to remove unreacted intermediates and byproducts.
-
-
π§ͺ Quality Control & Testing
-
The synthesized Arteether undergoes HPLC, NMR, IR, and MS analysis for:
-
Assay
-
Purity
-
Residual solvents
-
Stereochemical integrity
-
-
-
π️ Final API Processing
-
Final drying, milling (if needed), and sieving are performed.
-
The product is then packed in airtight, light-resistant containers under nitrogen, depending on stability requirements.
-
π§΄ Regulatory & Safety Considerations
-
GMP Compliance: Manufacturing is done under strict GMP guidelines.
-
Documentation: Includes DMF (Drug Master File), COA (Certificate of Analysis), and MSDS.
-
Environmental Safety: Solvent recovery systems are used to ensure green chemistry compliance.πΏ
π Different Dosage Forms of Arteether API
1. Intramuscular Injection (IM)
-
π Most common and effective formulation
-
Strengths:
-
150 mg/2 ml
-
80 mg/ml
-
-
Formulation:
-
Oily solution (e.g., in sesame oil or arachis oil)
-
-
Indication: Used in acute malaria, particularly when oral administration is not feasible.
2. Combination Injections
-
π Arteether + Lumefantrine (in R&D or combination therapy contexts)
-
Designed to enhance the antimalarial spectrum and reduce resistance development.
3. Oral (Experimental/Under Development)
-
π¦ Not commonly available commercially due to:
-
Low water solubility
-
Poor oral bioavailability
-
-
However, nanoformulations and lipid-based delivery systems are being researched to overcome this.
4. Pediatric Formulations
-
π Research is ongoing to adapt dosage and formulation for pediatric patients in malaria-endemic areas (e.g., taste-masked suspensions or dispersible tablets — not yet widely commercialized for Arteether).
π§΄ Packaging & Administration
-
IM Form: Packed in amber glass ampoules/vials to protect from light
-
Storage: 2–8°C; avoid freezing ❄️
-
Route: Deep intramuscular injection, usually administered in a 3-dose schedule (once daily over 3 days)
Great question! π Here's a detailed breakdown of how the dosage forms of ARTEETHER API—especially the intramuscular injection—are prepared by manufacturers like Swapnroop Drugs & Pharmaceuticals under stringent GMP standards:
π Preparation of ARTEETHER Injectable Dosage Form (IM)
π 1. API Handling & Pre-formulation
-
Arteether API is received under GMP-grade, vacuum-sealed packaging.
-
Quality checks (assay, purity, polymorphic form) are conducted.
-
Solubility studies confirm optimal oil-based solvents (e.g., sesame oil, arachis oil).
⚗️ 2. Formulation Components
| Component | Purpose |
|---|---|
| Arteether API | Active antimalarial agent |
| Sesame Oil / Peanut Oil | Solvent/Vehicle for oily injection |
| Benzyl Alcohol (optional) | Preservative |
| Nitrogen | Inert gas for displacement of air in ampoules |
π§ͺ 3. Manufacturing Steps
-
Dissolution of API:
-
Arteether is dissolved in sterile, filtered oil at controlled temperature (30–40°C).
-
Stirred under nitrogen to prevent oxidation.
-
-
Filtration:
-
The oily solution is filtered through 0.22-micron sterilizing filters into a sterile holding tank.
-
-
Aseptic Filling:
-
Under Class 100 (ISO 5) laminar airflow:
-
The sterile solution is filled into amber-colored glass ampoules/vials (usually 2 ml or 3 ml).
-
Nitrogen may be flushed into the headspace to prevent oxidative degradation.
-
-
-
Sealing:
-
Ampoules are flame-sealed or rubber-stoppered vials are crimped.
-
-
Terminal Sterilization (if needed):
-
Some processes include low-temperature steam sterilization or dry heat, depending on oil and container compatibility.
-
π¦ 4. Packaging & Labeling
-
Ampoules are packed in blisters or cartons with:
-
Product leaflet
-
Batch number
-
Manufacturing/expiry dates
-
-
Secondary packaging ensures protection from light and moisture.
π§ͺ 5. Quality Control Tests
| Test | Parameters |
|---|---|
| Appearance | Clear, pale yellow solution |
| Assay | Typically 95–105% of label claim |
| pH | Within acceptable parenteral range |
| Sterility | Must pass |
| Particulate Matter | As per pharmacopeial limits |
| Viscosity | Measured for injectability |
| Identification | IR/NMR confirmation |
| Impurity Profile | As per ICH Q3A/B standards |
π Storage & Stability
-
Temperature: 2–8°C
-
Shelf Life: Up to 24–36 months in sealed, light-resistant containers
-
Stability: Periodic stability studies under ICH guidelines (zone IVb if exported to tropical regions)
π ARTEETHER API, manufactured by Swapnroop Drugs & Pharmaceuticals, is formulated primarily for injectable use in the treatment of malaria, especially when oral therapy is not possible or resistance to other antimalarials is suspected.
π©Ί When Should Arteether Be Taken?
1. Indicated Use
✔️ For treatment of severe or complicated malaria, especially chloroquine-resistant Plasmodium falciparum infections.
✔️ Often used as a second-line or adjunctive therapy when first-line oral agents cannot be administered.
π Dosage Schedule (for adults and children)
-
Standard regimen:
-
150 mg intramuscularly once daily
-
For 3 consecutive days
-
⚠️ Administered under strict medical supervision, especially in hospitalized settings or areas with malaria outbreaks.
π¨ Clinical Situations Requiring Arteether Use
| Situation | Reason |
|---|---|
| π Chloroquine failure | Arteether is effective against resistant strains |
| π€ Unconscious or vomiting patients | Oral therapy is not feasible |
| π₯ Hospital setting | Rapid antimalarial action is needed |
| π¦ High parasitemia levels | Quick reduction in parasite count is critical |
⛔ When NOT to Use Arteether
-
During the first trimester of pregnancy (unless life-threatening)
-
In cases of known hypersensitivity to artemisinin derivatives
-
Mild malaria cases (oral ACT preferred)
-
As monotherapy without follow-up ACT in some guidelines
π§ Key Takeaway
π Arteether is a powerful injectable weapon against resistant malaria and should be used in emergency or critical care settings, always under a physician’s prescription.
Would you like me to design a treatment guide card or physician information sheet with this info?
π§Ύπ
What are the effects and side effects of ARTEETHER API Manufactured by Swapnroop Drugs and Pharmaceuticals?




Comments
Post a Comment